View in EDS PDF Full Text

Reply to Rappaport et al.: Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.

Saved in:
Bibliographic Details
Title: Reply to Rappaport et al.: Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.
Authors: Dutt T; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom., Simcox D; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom., Downey C; Liverpool Clinical Laboratories Liverpool, United Kingdom and., McLenaghan D; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom., King C; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom., Gautam M; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom., Lane S; University of Liverpool Liverpool, United Kingdom., Burhan H; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom.
Source: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2020 Dec 15; Vol. 202 (12), pp. 1733-1734.
Publication Type: Letter; Comment
Journal Info: Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32931711
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reply to Rappaport et al.: Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dutt+T%22">Dutt T</searchLink>; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Simcox+D%22">Simcox D</searchLink>; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Downey+C%22">Downey C</searchLink>; Liverpool Clinical Laboratories Liverpool, United Kingdom and.<br /><searchLink fieldCode="AU" term="%22McLenaghan+D%22">McLenaghan D</searchLink>; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22King+C%22">King C</searchLink>; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gautam+M%22">Gautam M</searchLink>; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lane+S%22">Lane S</searchLink>; University of Liverpool Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Burhan+H%22">Burhan H</searchLink>; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229421642%22">American journal of respiratory and critical care medicine</searchLink> [Am J Respir Crit Care Med] 2020 Dec 15; Vol. 202 (12), pp. 1733-1734.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Thoracic+Society%22">American Thoracic Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9421642 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-4970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221073449X%22">1073449X </searchLink><i>NLM ISO Abbreviation: </i>Am J Respir Crit Care Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32931711
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1164/rccm.202007-2913LE
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1733
    Titles:
      – TitleFull: Reply to Rappaport et al.: Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dutt T
      – PersonEntity:
          Name:
            NameFull: Simcox D
      – PersonEntity:
          Name:
            NameFull: Downey C
      – PersonEntity:
          Name:
            NameFull: McLenaghan D
      – PersonEntity:
          Name:
            NameFull: King C
      – PersonEntity:
          Name:
            NameFull: Gautam M
      – PersonEntity:
          Name:
            NameFull: Lane S
      – PersonEntity:
          Name:
            NameFull: Burhan H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 12
              Text: 2020 Dec 15
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1535-4970
          Numbering:
            – Type: volume
              Value: 202
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: American journal of respiratory and critical care medicine
              Type: main
ResultId 1